A novel m6a-related genes signature can impact the immune status and predict the prognosis and drug sensitivity of lung adenocarcinoma

HIGHLIGHTS

• who: Xuewen Wang from the Jinan University, China have published the research work: A Novel M6A-Related Genes Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma, in the Journal: (JOURNAL)
• what: The authors aimed to construct an m6A-related genes signature to accurately predict the prognosis of LUAD patients.
• how: The prognostic risk score mode and nomogram were tested for their predictive power using ROC curves. The results showed that six m6A-related DEGs were identified between LUAD July 2022 | Volume 13 | Article 923533 M6A . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.